(Q45739051)

15 December 2017

title

Risk factors for active liver disease in HBeAg-negative chronic hepatitis B virus-infected patients (English)

1 reference

15 December 2017

1 reference

1 reference

Chan HL

1

1 reference

15 December 2017

Hui Y

2

1 reference

15 December 2017

Leung NW

3

1 reference

15 December 2017

Ching JY

4

1 reference

15 December 2017

Chan FK

5

1 reference

15 December 2017

Sung JJ

6

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

The American Journal of Gastroenterology

15 December 2017

published in

1 reference

15 December 2017

volume

95

1 reference

15 December 2017

issue

12

1 reference

15 December 2017

page(s)

3547-3551

1 reference

The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03373.X

Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03373.X

Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03373.X

Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03373.X

Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03373.X

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03373.X

Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03373.X

A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03373.X

Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03373.X

Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03373.X

10.1111/J.1572-0241.2000.03373.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference